S&P 500 slips from record Tuesday as chips rally takes a breather and inflation comes in hot: Live updates
Economists polled by Dow Jones were calling for headline CPI to have gained 3.7% from a year earlier.
Google says it likely thwarted effort by hacker group to use AI for ‘mass exploitation event’
Hackers are rapidly adopting AI to find previously unknown software flaws even without the help of Anthropic’s powerful Mythos model.
Trump says Iran ceasefire is ‘on life support’ after rejecting Tehran’s counter proposal
The testy U.S.-Iran ceasefire began in mid-April after Trump threatened to destroy Iran’s “whole civilization” if no deal was struck.
Microsoft CEO Satya Nadella takes stand in Musk v. Altman trial
Elon Musk named Microsoft as a defendant in his lawsuit against OpenAI
OpenAI trial: Nadella says Musk never raised concerns to him about Microsoft investment
Elon Musk named Microsoft as a defendant in his lawsuit against OpenAI
Former Tesla CFO Deepak Ahuja joins EV battery recycler Redwood Materials
Before joining Redwood Materials, Ahuja served as chief financial and business officer at the drone delivery startup Zipline for about three years.
UK should commit to rejoin the EU, London mayor tells CNBC
London mayor Sadiq Khan said that Prime Minister Keir Starmer should commit to rejoining the European Union and be “bigger and bolder.”
UK should commit to rejoin the EU, London mayor tells CNBC
London mayor Sadiq Khan said that Prime Minister Keir Starmer should commit to rejoining the European Union and be “bigger and bolder.”
Why AI demand is pushing data centers to the edge of Europe
Investment in data centers is surging. After more than $61 billion in deals in 2025, the sector is expected to require nearly $7 trillion by 2030 to meet rising AI demand. In Europe, data centers are moving away from saturated hubs toward accessible an…
Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatile
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.
